The India Percutaneous Coronary Intervention Market growth continues to accelerate as India's pharmaceutical and biotechnology sectors develop novel antithrombotic and antiproliferative therapies that enhance PCI outcomes in genetically and clinically distinct South Asian populations. With South Asians demonstrating higher rates of stent thrombosis and restentosis compared to Caucasian...